Epidemiology and Immune Pathogenesis of Viral Sepsis

被引:202
作者
Lin, Gu-Lung [1 ,2 ]
McGinley, Joseph P. [1 ,2 ]
Drysdale, Simon B. [1 ,2 ,3 ]
Pollard, Andrew J. [1 ,2 ]
机构
[1] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, England
[2] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England
[3] St Georges Univ Hosp NHS Fdn Trust, Dept Paediat, London, England
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
关键词
viral sepsis; epidemiology; immune pathogenesis; herpes simplex virus; human enterovirus; human parechovirus; influenza virus; dengue virus; HERPES-SIMPLEX-VIRUS; TOLL-LIKE-RECEPTOR; T-CELL DIFFERENTIATION; PRIMARY IMMUNODEFICIENCY DISEASES; RESPIRATORY-DISTRESS-SYNDROME; HUMAN PARECHOVIRUS TYPE-3; DECAY-ACCELERATING FACTOR; ENTEROVIRUS; 71; INFECTION; PEDIATRIC SEVERE SEPSIS; TUMOR-NECROSIS-FACTOR;
D O I
10.3389/fimmu.2018.02147
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis can be caused by a broad range of pathogens; however, bacterial infections represent the majority of sepsis cases. Up to 42% of sepsis presentations are culture negative, suggesting a non-bacterial cause. Despite this, diagnosis of viral sepsis remains very rare. Almost any virus can cause sepsis in vulnerable patients (e.g., neonates, infants, and other immunosuppressed groups). The prevalence of viral sepsis is not known, nor is there enough information to make an accurate estimate. The initial standard of care for all cases of sepsis, even those that are subsequently proven to be culture negative, is the immediate use of broad-spectrum antibiotics. In the absence of definite diagnostic criteria for viral sepsis, or at least to exclude bacterial sepsis, this inevitably leads to unnecessary antimicrobial use, with associated consequences for antimicrobial resistance, effects on the host microbiome and excess healthcare costs. It is important to understand non-bacterial causes of sepsis so that inappropriate treatment can be minimised, and appropriate treatments can be developed to improve outcomes. In this review, we summarise what is known about viral sepsis, its most common causes, and how the immune responses to severe viral infections can contribute to sepsis. We also discuss strategies to improve our understanding of viral sepsis, and ways we can integrate this new information into effective treatment.
引用
收藏
页数:21
相关论文
共 282 条
  • [81] Human parechovirus and enterovirus initiate distinct CNS innate immune responses: Pathogenic and diagnostic implications
    Fortuna, Danielle
    Cardenas, Ana Maria
    Graf, Erin H.
    Harshyne, Larry A.
    Hooper, D. Craig
    Prosniak, Michael
    Shields, John
    Curtis, Mark T.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2017, 86 : 39 - 45
  • [82] SEATTLE VIRUS WATCH .7. OBSERVATIONS OF ADENOVIRUS INFECTIONS
    FOX, JP
    HALL, CE
    COONEY, MK
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 105 (04) : 362 - 386
  • [83] Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
    Franceschi, Claudio
    Campisi, Judith
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2014, 69 : S4 - S9
  • [84] THE ABILITY OF RECOMBINANT MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO PROTECT NEONATAL RATS FROM SEPTIC DEATH DUE TO STAPHYLOCOCCUS-AUREUS
    FRENCK, RW
    SARMAN, G
    HARPER, TE
    BUESCHER, ES
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) : 109 - 114
  • [85] The pathogenesis of influenza virus infections: the contributions of virus and host factors
    Fukuyama, Satoshi
    Kawaoka, Yoshihiro
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (04) : 481 - 486
  • [86] Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections
    Fuller, MJ
    Khanolkar, A
    Tebo, AE
    Zajac, AJ
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (07) : 4204 - 4214
  • [87] Coronavirus NL63-induced Adult Respiratory Distress Syndrome
    Galante, Ori
    Avni, Yonat Shemer
    Fuchs, Lior
    Ferster, Ofira Azulay
    Almog, Yaniv
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (01) : 100 - 101
  • [88] Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I peptide complexes
    Gallimore, A
    Glithero, A
    Godkin, A
    Tissot, AC
    Plückthun, A
    Elliott, T
    Hengartner, H
    Zinkernagel, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) : 1383 - 1393
  • [89] Gea-Banacloche Juan C, 2004, Crit Care Med, V32, pS578, DOI 10.1097/01.CCM.0000143020.27340.FF
  • [90] ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis
    Goldstein, Brahm
    Nadel, Simon
    Peters, Mark
    Barton, Roger
    Machado, Flavia
    Levy, Howard
    Haney, Douglas J.
    Utterback, Barbara
    Williams, Mark D.
    Giroir, Brett P.
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2006, 7 (03) : 200 - 211